255 related articles for article (PubMed ID: 9705386)
41. Evaluation of a modified single-enzyme amplified-fragment length polymorphism technique for fingerprinting and differentiating of Mycobacterium kansasii type I isolates.
Gaafar A; Unzaga MJ; Cisterna R; Clavo FE; Urra E; Ayarza R; Martín G
J Clin Microbiol; 2003 Aug; 41(8):3846-50. PubMed ID: 12904399
[TBL] [Abstract][Full Text] [Related]
42. Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii.
Koeleman JG; van der Bijl MW; Stoof J; Vandenbroucke-Grauls CM; Savelkoul PH
Infect Control Hosp Epidemiol; 2001 May; 22(5):284-8. PubMed ID: 11428438
[TBL] [Abstract][Full Text] [Related]
43. Genomic typing of Escherichia coli O157:H7 by semi-automated fluorescent AFLP analysis.
Zhao S; Mitchell SE; Meng J; Kresovich S; Doyle MP; Dean RE; Casa AM; Weller JW
Microbes Infect; 2000 Feb; 2(2):107-13. PubMed ID: 10742682
[TBL] [Abstract][Full Text] [Related]
44. Comparison of ARDRA and recA-RFLP analysis for genomic species identification of Acinetobacter spp.
Jawad A; Snelling AM; Heritage J; Hawkey PM
FEMS Microbiol Lett; 1998 Aug; 165(2):357-62. PubMed ID: 9742709
[TBL] [Abstract][Full Text] [Related]
45. Identification of Acinetobacter species isolated from clinical specimens by amplified ribosomal DNA restriction analysis.
Chandra R; Kapil A; Sharma P; Das B
Indian J Med Res; 2002 Jul; 116():1-4. PubMed ID: 12514971
[TBL] [Abstract][Full Text] [Related]
46. Application of AFLP fingerprint analysis for studying the biodiversity of Streptococcus thermophilus.
Lazzi C; Bove CG; Sgarbi E; Gatti M; La Gioia F; Torriani S; Neviani E
J Microbiol Methods; 2009 Oct; 79(1):48-54. PubMed ID: 19647766
[TBL] [Abstract][Full Text] [Related]
47. Carriage of class 1 integrons and antibiotic resistance in clinical isolates of Acinetobacter baumannii from northern Spain.
Gallego L; Towner KJ
J Med Microbiol; 2001 Jan; 50(1):71-77. PubMed ID: 11192508
[TBL] [Abstract][Full Text] [Related]
48. Utility of Whole-Genome Sequencing in Characterizing Acinetobacter Epidemiology and Analyzing Hospital Outbreaks.
Fitzpatrick MA; Ozer EA; Hauser AR
J Clin Microbiol; 2016 Mar; 54(3):593-612. PubMed ID: 26699703
[TBL] [Abstract][Full Text] [Related]
49. Plasmid DNA fingerprinting of Acinetobacter species other than Acinetobacter baumannii.
Seifert H; Schulze A; Baginski R; Pulverer G
J Clin Microbiol; 1994 Jan; 32(1):82-6. PubMed ID: 8126208
[TBL] [Abstract][Full Text] [Related]
50. Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans.
Nemec A; Musílek M; Maixnerová M; De Baere T; van der Reijden TJ; Vaneechoutte M; Dijkshoorn L
Int J Syst Evol Microbiol; 2009 Jan; 59(Pt 1):118-24. PubMed ID: 19126734
[TBL] [Abstract][Full Text] [Related]
51. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
52. Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II.
Da Silva G; Dijkshoorn L; van der Reijden T; van Strijen B; Duarte A
Clin Microbiol Infect; 2007 Feb; 13(2):190-195. PubMed ID: 17328732
[TBL] [Abstract][Full Text] [Related]
53. Recognition of two novel phenons of the genus Acinetobacter among non-glucose-acidifying isolates from human specimens.
Nemec A; Dijkshoorn L; Jezek P
J Clin Microbiol; 2000 Nov; 38(11):3937-41. PubMed ID: 11060048
[TBL] [Abstract][Full Text] [Related]
54. Evaluation and comparison of random amplification of polymorphic DNA, pulsed-field gel electrophoresis and ADSRRS-fingerprinting for typing Serratia marcescens outbreaks.
Krawczyk B; Naumiuk L; Lewandowski K; Baraniak A; Gniadkowski M; Samet A; Kur J
FEMS Immunol Med Microbiol; 2003 Oct; 38(3):241-8. PubMed ID: 14522459
[TBL] [Abstract][Full Text] [Related]
55. Biodiversity of an Acinetobacter population isolated from activated sludge.
Barberio C; Fani R
Res Microbiol; 1998 Oct; 149(9):665-73. PubMed ID: 9826922
[TBL] [Abstract][Full Text] [Related]
56. Surveillance of nosocomial cross-infections due to three Acinetobacter genospecies (Acinetobacter baumannii, genospecies 3 and genospecies 13) during a 10-Year Observation period: serotyping, macrorestriction analysis of Genomic DNA and antibiotic susceptibilities.
Traub WH; Bauer D
Chemotherapy; 2000; 46(4):282-92. PubMed ID: 10859434
[TBL] [Abstract][Full Text] [Related]
57. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods.
Seifert H; Dijkshoorn L; Gerner-Smidt P; Pelzer N; Tjernberg I; Vaneechoutte M
J Clin Microbiol; 1997 Nov; 35(11):2819-25. PubMed ID: 9350741
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species.
Dijkshoorn L; Van Harsselaar B; Tjernberg I; Bouvet PJ; Vaneechoutte M
Syst Appl Microbiol; 1998 Mar; 21(1):33-9. PubMed ID: 9786720
[TBL] [Abstract][Full Text] [Related]
59. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU.
Higgins PG; Wisplinghoff H; Krut O; Seifert H
Clin Microbiol Infect; 2007 Dec; 13(12):1199-201. PubMed ID: 17850345
[TBL] [Abstract][Full Text] [Related]
60. Discrimination of Klebsiella pneumoniae and Klebsiella oxytoca phylogenetic groups and other Klebsiella species by use of amplified fragment length polymorphism.
Jonas D; Spitzmüller B; Daschner FD; Verhoef J; Brisse S
Res Microbiol; 2004; 155(1):17-23. PubMed ID: 14759704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
